Table 3.

		F	P*	Eta squared
Bax protein/β-actin (fold of control)	HIIT	2.190	0.1000	0.093
	CoQ10	0.680	0.7700	0.003
	HIIT × CoQ10	2.640	0.2400	0.180
Bcl-2 protein/β-actin (fold of control)	HIIT	9.620	0.0010	0.340
	CoQ10	4.490	0.0310	0.150
	HIIT × CoQ10	1.050	0.6400	0.008
Bax/Bcl-2	HIIT	3.910	0.0120	0.200
	CoQ10	1.350	0.4300	0.032
	HIIT × CoQ10	0.820	0.7400	0.003
Cytochrome c protein/β-actin (fold of control)	HIIT	5.090	0.0030	0.270
	CoQ10	1.860	0.1300	0.160
	HIIT × CoQ10	0.930	0.3700	0.004
Bid protein/β-actin (fold of control)	HIIT	11.420	0.0001	0.470
	CoQ10	0.750	0.3900	0.043
	HIIT × CoQ10	0.007	0.9300	0.001
Caspase-8 protein/β-actin (fold of control)	HIIT	12.740	0.0060	0.230
	CoQ10	2.140	0.2900	0.180
	HIIT × CoQ10	0.030	0.8700	0.004
Caspase-3 protein/β-actin (fold of control)	HIIT	6.810	0.0200	0.150
	CoQ10	0.880	0.4900	0.005
	HIIT × CoQ10	0.037	0.8600	0.002

^*Univariate analysis of variance (ANOVA)

HIIT: High-intensity interval training; CoQ10: Coenzyme Q10; Bcl-2: B-cell lymphoma-2; Bax: Bcl-2-associated X protein; Bid: BH3-interacting domain death agonist